Cargando…

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021

We investigated humoral immune responses in 222 unvaccinated Japanese people after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in 2021. Anti-spike-protein IgG antibody levels and neutralizing antibody titers were measured in serum samples obtained within 20–1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monzen, Koshiro, Watanabe, Takanori, Okabe, Toshihiro, Sekino, Hisakuni, Nakagami, Hironori, Morishita, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536507/ https://www.ncbi.nlm.nih.gov/pubmed/37766249 http://dx.doi.org/10.3390/v15091842

Ejemplares similares

Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)
por: Nakagami, Hironori, et al.
Publicado: (2023)

Recent Progress in Therapeutic Angiogenesis
por: Nakagami, Hironori, et al.
Publicado: (2007)

Appropriate Needle Length Determined by Ultrasonic Echography for Intramuscular Injection in Japanese Elderly over 50 Years
por: Nakayama, Tetsuo, et al.
Publicado: (2022)

Efficacy of Early Cardiac Rehabilitation After Cardiac Surgery　― Verification Using Japanese Diagnosis Procedure Combination Data ―
por: Sezai, Akira, et al.
Publicado: (2022)

Peptide Vaccines for Hypertension and Diabetes Mellitus
por: Nakagami, Hironori, et al.
Publicado: (2014)

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes
por: Sezai, Akira, et al.
Publicado: (2019)

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019)

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
por: Shimamura, Munehisa, et al.
Publicado: (2013)

Lymphedema and Therapeutic Lymphangiogenesis
por: Saito, Yukihiro, et al.
Publicado: (2013)

Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
por: Shiba, Sari, et al.
Publicado: (2020)

Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
por: Adamec, Ivan, et al.
Publicado: (2022)

Evaluating the Safety, Tolerability, and Disposition of Trazpiroben, a D(2)/D(3) Receptor Antagonist: Phase I Single‐ and Multiple‐Ascending Dose Studies in Healthy Japanese Participants
por: Yamaguchi, Takayoshi, et al.
Publicado: (2021)

Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)

RANKL system in vascular and valve calcification with aging
por: Kawakami, Ryo, et al.
Publicado: (2016)

Brief report on a phase I/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension
por: Nakagami, Hironori, et al.
Publicado: (2021)

HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS
por: Sabin, Albert B., et al.
Publicado: (1936)

Humoral and cellular response in convalescent COVID-19 lupus patients
por: Solé, Cristina, et al.
Publicado: (2022)

Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
por: Habek, Mario, et al.
Publicado: (2022)

Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway
por: Tomioka, Hideki, et al.
Publicado: (2014)

Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People
por: Otsubo, Naoya, et al.
Publicado: (2022)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD
por: Fukushima, Yasushi, et al.
Publicado: (2018)

Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
por: Dewald, Felix, et al.
Publicado: (2023)

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function
por: Miyatake, Daisuke, et al.
Publicado: (2019)

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020)

Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a)
por: Kyutoku, Mariko, et al.
Publicado: (2013)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020)

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013)

A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia
por: Sezai, Akira, et al.
Publicado: (2023)

A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches
por: Sezai, Akira, et al.
Publicado: (2023)

The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence
por: Silva, Vânia Lúcia, et al.
Publicado: (2021)

Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV()
por: Giannone, Denise, et al.
Publicado: (2022)

The Japanese Catheter Ablation Registry (J‐AB): Annual report in 2021
por: Kusano, Kengo, et al.
Publicado: (2023)

SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
por: Yoshida, Shota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4ht62fn3hh20tpt9ojl4cfslt